DNAJC5 and parasitic infectious disease: If mice are treated with atovaquone during the blood-stage of the infection, parasitemia is cleared and animals present a subsequent enhancement in the number of splenic B cells, GC B cells, plasmablasts and anti-CSP antibody titers as observed with IrSPz-immunized mice (67).